Author:
Bhowmik Debajyoti,Aparasu Rajender R.,Rajan Suja S.,Sherer Jeffrey T.,Ochoa-Perez Melissa,Chen Hua
Subject
Psychiatry and Mental health,Clinical Psychology
Reference33 articles.
1. Mortality of patients with mood disorders: follow-up over 34–38 years;Angst;Journal of Affective Disorders,2002
2. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence;Baldessarini;Psychiatric Services,2008
3. Medication use in children and adolescents treated in the community for bipolar disorder;Bhangoo;Journal of Child and Adolescent Psychopharmacology,2003
4. Bristol-Myers Squibb (BMS) website, 2007. US Food and Drug Administration approves Abilify (aripiprazole) as the first medication for add-on treatment of major depressive disorder (MDD). (Available from: 〈http://news.bms.com/press-release/us-food-and-drug-administration-approves-abilify-aripiprazole-first-medication-add-tre〉) (accessed 12.01.13.).
5. Bipolar-I depression outpatient treatment quality and costs in usual care practice;Busch;Psychopharmacology Bulletin,2008
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献